Evidence map›Paper›PMID 39252894›Full record

ArticlemedRxiv : the preprint server for health sciences2024

Technical Development and In Silico Implementation of SyntheticMR in Head and Neck Adaptive Radiation Therapy: A Prospective R-IDEAL Stage 0/1 Technology Development Report.

Lucas McCullum, Samuel Mulder, Natalie West, Robert Aghoghovbia, Alaa Mohamed Shawky Ali, Hayden Scott, Travis C Salzillo, Yao Ding, Alex Dresner, Ergys Subashi and 4 more

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Lucas McCullumUT MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, USA.ORCID 0000-0001-9788-7987
Samuel MulderUT MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, USA.ORCID 0000-0001-5185-4805
Natalie WestUT MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, USA.ORCID 0009-0007-0211-8845
Robert AghoghovbiaMorehouse School of Medicine, Atlanta, USA.ORCID 0009-0008-2944-4584
Alaa Mohamed Shawky AliDepartment of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID 0000-0001-7472-3701
Hayden ScottUT MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, USA.ORCID 0000-0003-1066-1999
Travis C SalzilloDepartment of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID 0000-0001-6271-9879
Yao DingDepartment of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID 0000-0002-0559-5846
Alex DresnerPhilips Healthcare MR Oncology, Cleveland, Ohio, USA.ORCID 0000-0002-0469-6012
Ergys SubashiDepartment of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID 0000-0001-5168-6928
Dan MaDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, USA.ORCID 0000-0003-1664-9579
R Jason StaffordDepartment of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID 0000-0003-4091-8417
Ken-Pin HwangDepartment of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID 0000-0002-8196-3794
Clifton D FullerDepartment of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID 0000-0002-5264-3994

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI DIANE BODURKA · 1985 to 2026
$290.8M
Development of functional magnetic resonance imaging-guided adaptive radiotherapy for head and neck cancer patients using novel MR-Linac deviceR01DE028290 · NIDCR · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI CHRISTODOULEAS, JOHN PAUL, FULLER, CLIFTON DAVID · 2019 to 2023
$4.3M
NRSA Training CoreTL1TR003169 · NCATS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI CHANDRA, JOYA, FROST, JEFFREY A. · 2019 to 2023
$3.7M
Development of fast diffusion magnetic resonance fingerprinting of the prostate to avoid unnecessary biopsiesR01CA292091 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI Yong Chen, Leonardo Kayat Bittencourt · 2024 to 2026
$3.2M
Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) to Establish Objective Clinical Outcome Measures for Mandibular OsteoradionecrosisR01DE025248 · NIDCR · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI LAI, STEPHEN Y · 2016 to 2020
$2.9M
Development of Magnetic Resonance Fingerprinting (MRF) to Assess Response to Neoadjuvant Chemotherapy in Breast CancerR01CA282516 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI Yong Chen, Dan Ma · 2023 to 2026
$2.4M
SCH: Personalized Rescheduling of Adaptive Radiation Therapy for Head & Neck CancerR01CA257814 · NCI · RICE UNIVERSITY · PI FULLER, CLIFTON DAVID, SCHAEFER, ANDREW J · 2021 to 2024
$1.8M
MR Fingerprinting based Quantitative Imaging and Analysis Platform (MRF-QIA) for brain tumors.R01CA269604 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI BADVE, CHAITRA, DAVATZIKOS, CHRISTOS · 2023 to 2025
$1.7M
Fellow and Resident Radiation Oncology iNtensive Training in Imaging and Informatics to Empower Research Careers (FRONTI2ER)R25EB025787 · NIBIB · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI DAS, PRAJNAN, FULLER, CLIFTON DAVID · 2018 to 2022
$535k
Radiation-specific Automated Dental Dose Distributions via Machine-learning based Mapping for Accurate Predictions of (Peri)odontal Problems (RADMAP)R21DE031082 · NIDCR · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI MORENO, AMY CATHERINE · 2021 to 2022
$452k
NCATS NIH HHS TL1 TR003169NCI NIH HHS P30 CA016672NCI NIH HHS R01 CA257814NCI NIH HHS R01 CA269604NCI NIH HHS R01 CA282516NCI NIH HHS R01 CA292091NIBIB NIH HHS R25 EB025787NIDCR NIH HHS R01 DE025248NIDCR NIH HHS R01 DE028290NIDCR NIH HHS R21 DE031082
6 · The paper itself

Abstract

Objective: The purpose of this study was to investigate the technical feasibility of integrating the quantitative maps available from SyntheticMR into the head and neck adaptive radiation oncology workflow. While SyntheticMR has been investigated for diagnostic applications, no studies have investigated its feasibility and potential for MR-Simulation or MR-Linac workflow. Demonstrating the feasibility of using this technique will facilitate rapid quantitative biomarker extraction which can be leveraged to guide adaptive radiation therapy decision making. Approach: Two phantoms, two healthy volunteers, and one patient were scanned using SyntheticMR on the MR-Simulation and MR-Linac devices with scan times between four to six minutes. Images in phantoms and volunteers were conducted in a test/retest protocol. The correlation between measured and reference quantitative T1, T2, and PD values were determined across clinical ranges in the phantom. Distortion was also studied. Contours of head and neck organs-at-risk (OAR) were drawn and applied to extract T1, T2, and PD. These values were plotted against each other, clusters were computed, and their separability significance was determined to evaluate SyntheticMR for differentiating tumor and normal tissue. Main Results: The Lin's Concordance Correlation Coefficient between the measured and phantom reference values was above 0.98 for both the MR-Sim and MR-Linac. No significant levels of distortion were measured. The mean bias between the measured and phantom reference values across repeated scans was below 4% for T1, 7% for T2, and 4% for PD for both the MR-Sim and MR-Linac. For T1 vs. T2 and T1 vs. PD, the GTV contour exhibited perfect purity against neighboring OARs while being 0.7 for T2 vs. PD. All cluster significance levels between the GTV and the nearest OAR, the tongue, using the SigClust method was p < 0.001. Significance: The technical feasibility of SyntheticMR was confirmed. Application of this technique to the head and neck adaptive radiation therapy workflow can enrich the current quantitative biomarker landscape.

Indexed as

Adaptive Radiation TherapyHead and Neck CancerMRIMR-LinacQuantitative ImagingRadiation TherapyRadiotherapySyMRISyntheticMR

Identifiers

PMID39252894
PMCPMC11383512

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.